v3.26.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Operating activities    
Net loss $ (2,483,000) $ (2,399,000)
Adjustments to reconcile loss to net cash used in operating activities:    
Share-based compensation 197,000 147,000
Depreciation and amortization 3,000 2,000
Changes in operating assets and liabilities:    
Accounts receivable 140,000 (176,000)
Inventories (52,000) (85,000)
Prepaid expenses 9,000 4,000
Accounts payable and accrued liabilities 52,000 205,000
Interest on note payable 396,000 287,000
Net cash used in operating activities (1,738,000) (2,015,000)
Financing activities    
Net proceeds from private placement 1,003,000
Net proceeds from convertible notes payable to related parties 970,000 2,000,000
Net cash provided by financing activities 1,973,000 2,000,000
Net increase (decrease) in cash, cash equivalents, and restricted cash 235,000 (15,000)
Cash, cash equivalents, and restricted cash at beginning of year 409,000 424,000
Cash, cash equivalents, and restricted cash at end of year 644,000 409,000
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets    
Cash and cash equivalents 569,000 334,000
Restricted cash 75,000 75,000
Total cash, cash equivalents and restricted cash 644,000 409,000
Supplemental disclosure of cash flow information    
Cash paid for taxes $ 5,000 $ 3,000